CD22 and congenital rubella syndrome: Some risk factors for IEC-HS overlap with those for CRS, including high disease burden and baseline inflammation, while others, such as the CAR-T cell antigen target (e.g., CD22), may be specific to IEC-HS; however, further research is required to fully elucidate its biology (2).